Trials / Completed
CompletedNCT05209139
Beetroot Juice Ingestion Effects on Field Hockey Performance.
Acute Effects of Beetroot Juice Ingestion on Neuromuscular Performance and Match-play Demands in Elite Female Hockey Players.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Universidad Francisco de Vitoria · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Scientific evidence supports that only a few dietary supplements have reported good evidence for improving sports performance, between we can mention beetroot juice supplementation with doses \> 5 mmol of NO3-. In this randomized placebo-controlled study, we investigated the effects of BJ acute supplementation in improving neuromuscular performance and match-play demands in female field hockey players.
Detailed description
Beetroot juice supplementation has demonstrated good evidence for improving sports performance, however, benefits in team sports, especially in female athletes, are underrepresented. In this randomized placebo-controlled study, we investigated the effects of beetroot juice acute supplementation in improving neuromuscular performance and match-play demands.Testing sessions will comprise a neuromuscular test battery consisting of a countermovement jump (CMJ), isometric handgrip strength, 20-m sprint and repeated sprint ability test, followed by a 20-minute simulated field hockey Physical match activity (distances, speeds, accelerations and decelerations) will be monitored in real-time using an inertial tracking system
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Beetroot juice | One serving 70 mL of beetroot juice (6.4 mmol of NO3-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) 3 h before initiating the testing session. |
| DIETARY_SUPPLEMENT | Beetroot juice placebo | One serving 70 mL of beetroot juice placebo (0.04 mmol of NO3-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) 3 h before initiating the testing session. |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2018-03-08
- Completion
- 2018-03-15
- First posted
- 2022-01-26
- Last updated
- 2022-04-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05209139. Inclusion in this directory is not an endorsement.